These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 6446384

  • 21. [Nonparametric approach to the determination of critical diameters. Comparison with conventional methods].
    Flandrois JP, Carret G.
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):488-91. PubMed ID: 6087246
    [Abstract] [Full Text] [Related]

  • 22. Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media.
    Jones RN, Barry AL, Thornsberry C.
    Diagn Microbiol Infect Dis; 1986 Apr; 4(4):345-9. PubMed ID: 3698547
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.
    Jones RN, Gavan TL, Barry AL, Thornsberry C, Gibbs DL.
    J Clin Microbiol; 1982 May; 15(5):777-86. PubMed ID: 6212596
    [Abstract] [Full Text] [Related]

  • 26. Activities of cefoperazone, cefotaxime, cefuroxime, and cephalothin against 128 clinical isolates.
    Garcia-Rodriguez JA.
    Clin Ther; 1980 May; 3(Spec Issue):117-22. PubMed ID: 6248220
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Penicillin-resistance as indicator of resistance of Staphylococcus aureus towards cephalosporines and structure-related substances (author's transl)].
    Hirschl A, Stanek G, Rotter M.
    Zentralbl Bakteriol A; 1981 Feb; 248(4):463-8. PubMed ID: 6784390
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A comparative study of the in-vitro activity of cefepime and other cephalosporins.
    Lim VK, Halijah MY.
    Malays J Pathol; 1993 Jun; 15(1):65-8. PubMed ID: 8277793
    [Abstract] [Full Text] [Related]

  • 31. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
    Jones RN, Fuchs PC, Barry AL, Gavan TL, Gerlach EH, Sommers HM.
    Clin Ther; 1980 Jun; 3(Spec Issue):14-23. PubMed ID: 6446389
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Antimicrobial susceptibility tests with cefotaxime and correlation with clinical bacteriologic response.
    Thornsberry C, Jones RN, Barry AL, Fuchs PC.
    Rev Infect Dis; 1982 Jun; 4 Suppl():S316-24. PubMed ID: 6294780
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Inability of the standardized disk agar-diffusion test to measure susceptibility of the fluorescent group of pseudomonads to gentamicin.
    Woolfrey BF, Ramadei WA, Quall CO.
    Am J Clin Pathol; 1978 Sep; 70(3):337-42. PubMed ID: 101077
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.